Quick Answer
Revolution Medicines, Inc. reported Shares Outstanding of 197.00 million shares for fiscal year 2025.
Revolution Medicines, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 197.00M | +6.0% |
| 2024 | 185.90M | +12.9% |
| 2023 | 164.67M | +82.1% |
| 2022 | 90.41M | +21.9% |
| 2021 | 74.14M | +11.3% |
| 2020 | 66.60M | +1923.0% |
| 2019 | 3.29M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 189.71M | +13.1% | +1.5% |
| June 30, 2025 | 186.90M | +12.8% | +0.3% |
| March 31, 2025 | 186.26M | +12.9% | +0.2% |
| December 31, 2024 | 185.90M | +12.9% | +10.8% |
| September 30, 2024 | 167.75M | +53.3% | +1.3% |
| June 30, 2024 | 165.65M | +51.8% | +0.4% |
| March 31, 2024 | 164.91M | +55.1% | +0.1% |
| December 31, 2023 | 164.67M | +82.1% | +50.5% |
- Revolution Medicines, Inc. showed an increase of +6.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Revolution Medicines, Inc.’s shares outstanding has grown by 5884.0% (from 3.29 million shares to 197.00 million shares).
- The most recent figure is from Revolution Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: